Metacognition Assessment in Patient With Multiple Sclerosis

This study will assessed the level of consciousness of MS patients suffering of cognitive and motor disorders. Understanding the awareness of the disease is crucial to allow better management of these patients. It has been shown, for other neurological pathologies, that a lack of awareness of deficits leads to inefficient rehabilitation and a disorder of understanding the impact of deficits in daily activities. Metacognition could be altered with age, so we will include participants between 18 and 60 years old.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Multiple Sclerosis Autoimmune Diseases Autoimmune Diseases of the Nervous System Demyelinating Autoimmune Diseases, CNS Demyelinating Diseases Immune System Diseases Nervous System Diseases

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Chu Grenoble Alpes

Grenoble, 38043, France

About this study

Subject who have to do neurological assessement by the Multiple sclerosis Functional Composite (MSFC) will be enrolled.

The patient will estimate the time to undergo the test. This time will be compared to the time really make by the patient to realise test.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Diagnosis of multiple sclerosis
Voluntary for participate to study

Exclusion criteria

Neurological disease other than Multiple Sclerosis
psychiatric disease, other than depressiveness
illicit substance abuse
Persons referred to in Articles L1121-5 to 8 of the French Public Health Code

Treatment and study plan

Primary outcomes

Metacognitive precision

Time frame: Day 1

Metacognitive precision based on Multiple Sclerosis Functional Composite (MSFC) score

Sponsors and collaborators

Lead sponsor

University Hospital, Grenoble

Other

Collaborators

University Grenoble Alps

Registry information

Acronym: METACOGSEP

Important dates

Study start: 2020
Primary completion: 2022
Study completion: 2022
First posted: Jan 27, 2020
Registry last updated: Jun 1, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed